FEM
  • Home
  • About FEM
  • Team
  • Psychedelics 101
    • Ketamine
    • MDMA
    • Psilocybin
    • LSD
    • Cannabis
  • Research & Academia
  • Aerospace and Science
  • Events & Media
  • Gallery
  • Contact Us
  • More
    • Home
    • About FEM
    • Team
    • Psychedelics 101
      • Ketamine
      • MDMA
      • Psilocybin
      • LSD
      • Cannabis
    • Research & Academia
    • Aerospace and Science
    • Events & Media
    • Gallery
    • Contact Us
FEM
  • Home
  • About FEM
  • Team
  • Psychedelics 101
    • Ketamine
    • MDMA
    • Psilocybin
    • LSD
    • Cannabis
  • Research & Academia
  • Aerospace and Science
  • Events & Media
  • Gallery
  • Contact Us

PSILOCYBIN

Additional Information

What is Psilocybin?


Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. It belongs to a class of compounds known as tryptamines. Psilocybin is the active compound that, when ingested, gets converted to psilocin in the body, which is responsible for its psychoactive effects.

Psilocybin-containing mushrooms, often referred to as "magic mushrooms" or simply "shrooms," have a long history of use in various cultures for spiritual, religious, and recreational purposes. They have been used for centuries, if not longer, in ceremonial rituals and healing practices.

When consumed, psilocybin produces profound changes in perception, cognition, and mood. Its effects can include altered sensory perception, visual and auditory hallucinations, changes in thought patterns, enhanced introspection, and a sense of interconnectedness or unity with the surrounding world. The experience is often described as a "trip" and can vary in intensity and duration depending on factors such as dosage, individual sensitivity, and the specific mushroom species consumed.


Research into the therapeutic potential of psilocybin has gained significant attention in recent years. Clinical trials have explored its use in the treatment of mental health conditions such as depression, anxiety, addiction, and end-of-life distress in individuals with life-threatening illnesses. Preliminary results from these studies have shown promising outcomes, but further research is still needed to establish its safety and efficacy as a therapeutic intervention.


It's important to note that the use of psilocybin-containing mushrooms is illegal in many countries, including the United States. However, there are exceptions in some jurisdictions where supervised research or religious practices are permitted. If you have questions about the legal status of psilocybin in your specific location, it is best to consult local laws or legal professionals.


As with any psychoactive substance, it's crucial to approach the use of psilocybin with caution and under appropriate circumstances. Uncontrolled and recreational use without proper knowledge and preparation can lead to unpredictable experiences and potential risks. If you are considering using psilocybin or exploring its potential therapeutic benefits, it is advisable to seek guidance from medical professionals, licensed therapists, or organizations involved in clinical research.


Psilocybin & Clinical Research

  • One of the most well-known studies in psychedelic therapy is the Concord Prison Experiment headed by Dr. Timothy Leary. A follow-up study ~30 years later reconfirmed it was an important step forward for psychedelic research in showing that hallucinogenic substances like psilocybin can have immense healing potential, but only with the right context and follow-through. https://psychedelictimes.com/psychedelic-rehabilitation-can-psilocybin-mushrooms-reduce-recidivism/ 
  • Over 27,000 scientific articles have been published on psychedelic drugs, with over 1000 particularly on psilocybin. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156539/
  • There is adequate evidence to support a direct clinical study of psilocybin-assisted therapy for the treatment of PTSD. https://www.jns-journal.com/article/S0022-510X(22)00164-2/fulltext 
  • Proprietary psilocybin has the ability to target visceral fat, effectively reducing weight gain in obese subjects. https://psychedelicspotlight.com/psilocybin-is-effective-in-reducing-weight-gain-new-study-shows/
  • Antidepressant effects of psilocybin-assisted therapy may be durable at least through 12 months following acute intervention in some patients. https://pubmed.ncbi.nlm.nih.gov/35166158/
  • How 4 Indigenous Cultures Currently Use Psychedelics. https://psychedelicspotlight.com/how-indigenous-cultures-currently-use-psychedelics/


Molecular Structure for Psilocybin

Molecular Structure for Psilocybin

Copyright © 2025 FEM - All Rights Reserved.

  • Home
  • About FEM
  • Team
  • Research & Academia
  • Aerospace and Science
  • Events & Media
  • Gallery
  • Contact Us

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept